How long should I wait to perform a tuberculin skin test after receiving the MMR vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Tuberculin Skin Test After MMR Vaccination

If you need to perform a tuberculin skin test (TST) after MMR vaccine administration, wait at least 4 weeks (preferably 4-6 weeks) before placing the TST, or ideally administer both on the same day with TST reading at 48-72 hours. 1, 2, 3

Optimal Timing Strategy

The best approach follows this algorithm:

First-line option (preferred):

  • Administer the TST and MMR vaccine on the same day 1, 2
  • Read the TST at 48-72 hours, before any vaccine-induced immunosuppression occurs 1, 2
  • This ensures the person receives measles protection while obtaining accurate TST results 1

If MMR was already given:

  • Wait at least 4 weeks after MMR vaccination before placing the TST 1, 3
  • The FDA label for MMR vaccine specifically states the TST should be administered "before, simultaneously with, or at least 4 to 6 weeks after vaccination" 3
  • This delay removes concern about transient suppression of TST reactivity from the vaccine 1

Least preferred option:

  • Perform and read TST before administering MMR vaccine 1
  • This delays measles protection and should only be used when same-day administration is not feasible 1

Why This Timing Matters

Immunologic mechanism:

  • Live attenuated measles vaccine can theoretically suppress delayed-type hypersensitivity reactions, including TST reactivity 1, 3
  • This immunosuppression can cause false-negative TST results if testing occurs during the suppression window 1, 2
  • The degree of suppression from vaccine is likely less than from wild-type measles infection, but still clinically significant 1

Duration of suppression:

  • Vaccine-induced immunosuppression begins shortly after vaccination 2
  • The suppression can persist for 4-6 weeks 1, 2, 3
  • Testing during this 1-4 week window is the peak period for false-negative results 2

Extension to Other Live Vaccines

This guidance applies to all live-attenuated viral vaccines:

  • Varicella vaccine 1
  • Yellow fever vaccine 1
  • Smallpox vaccine (requires 4-week delay) 1
  • No specific data exist for these vaccines, but following measles vaccine guidelines is prudent 1

Alternative Testing Option

If timing is problematic:

  • Consider using an interferon-gamma release assay (IGRA) instead of TST 2
  • IGRAs are not affected by live vaccines and require only a single visit 2, 4
  • This is particularly useful when TB screening is urgent and cannot wait 4-6 weeks 2

Common Pitfalls to Avoid

Critical timing errors:

  • Never place a TST 1-4 weeks after MMR vaccination - this is the peak immunosuppression period and will likely yield false-negative results 2
  • Do not delay necessary MMR vaccination just to perform TST first, unless there is high clinical suspicion for active tuberculosis requiring immediate evaluation 1, 2
  • Do not confuse this 4-6 week vaccine timing with the 8-10 week window for TB exposure testing, which is a completely different concept 2, 5

Documentation issues:

  • Ensure proper documentation of vaccination dates to avoid inappropriate TST timing 2
  • If TST was inadvertently placed during the suppression window, repeat testing after the appropriate interval 1

Special populations:

  • Persons with untreated active tuberculosis should have antituberculosis therapy initiated before receiving MMR, as measles vaccine might theoretically exacerbate tuberculosis disease 1
  • TST reactivity itself (in absence of active disease) is not a contraindication to MMR vaccination 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of TB Skin Test After Live Vaccine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Two-Step Tuberculin Skin Testing Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

PPD Screening for Tuberculosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.